Eczema Treatment: Evidence-Based Options for Every Severity

Understanding Eczema Treatment: Why One Size Does Not Fit All

If you have ever wondered why the same cream works wonders for your sister but does nothing for you, here is the reason: eczema is not a single disease. It is actually a group of chronic inflammatory skin conditions that share common features like intense itch, a damaged skin barrier, and immune dysregulation (an immune system that overreacts to harmless triggers). Think of it like the word "headache," which can mean a tension headache, a migraine, or a sinus headache, each needing a different fix. Understanding the full range of eczema symptoms can help you recognize where your condition falls on the severity spectrum.^[4] Because the root causes of eczema vary from person to person, no single treatment works for everyone. Your eczema type, severity, body location, and age all shape which therapies will help you most. For a detailed breakdown of how presentation shifts across life stages, see our guide to eczema by age group.

International guidelines now recommend a stepwise treatment approach. You start with the least aggressive options and escalate only when needed.^[3] This protects you from unnecessary side effects while keeping stronger tools available for tougher flares. Knowing how to treat atopic dermatitis well starts with identifying which of the different types of eczema you have.

The Three Pillars of Eczema Management

Effective eczema treatment rests on three pillars, and most failed treatment plans neglect at least one of them. Think of it like a three-legged stool: remove any leg and the whole thing tips over.

• Inflammation control: Calming the overactive immune response that drives redness, swelling, and itch. Topical steroids, calcineurin inhibitors, and biologics all target this pillar.^[5]
• Skin barrier repair: Restoring the damaged outer layer that lets moisture escape and irritants enter. Eczema-affected skin loses water through evaporation (called transepidermal water loss) at a much higher rate than healthy skin, like a roof with missing shingles letting heat escape in winter.^[6] Our guide on why your skin barrier keeps failing covers the lipid science in depth.
• Microbiome support: Rebalancing the skin's microbial community. Eczema skin is often dominated by Staphylococcus aureus, which worsens inflammation and disrupts barrier function.^[7]

When you address all three pillars together, each one reinforces the others. A repaired barrier supports a healthier microbiome. A balanced microbiome reduces inflammation. Lower inflammation lets the barrier heal faster. To understand how the microbiome fits into this picture, see our guide on what the skin microbiome is and why it matters.

Matching Treatment to Severity

Dermatologists classify eczema severity as mild, moderate, or severe based on body surface area affected, itch intensity, and impact on sleep and daily life.^[8] Your severity level determines your starting point on the treatment ladder.

Mild eczema often responds to moisturizers and short courses of low-potency topical steroids, while moderate eczema typically requires prescription topicals or combination OTC approaches.^[3] Severe eczema may demand systemic therapies, biologics, or phototherapy. But here is the key: foundational care with moisturizers applies at every severity level, no matter where you fall on the ladder.

Foundational Care: Moisturizers, Emollients, and the Soak-and-Seal Method

If you have ever felt that tight, papery sensation in your skin after a hot shower, you already know why moisturizing matters. It is the one step that every eczema treatment plan shares. Regular use of emollients (moisturizing products that soften and seal the skin) improves hydration, supports barrier function, and reduces the need for prescription anti-inflammatories during mild disease. To understand the science behind how these products work, see our guide on how moisturizers work. Yet moisturizers alone rarely control active eczema. Think of them as the foundation of a house: essential, but not the whole structure.

One important note about prevention: the large BEEP randomized trial of 1,394 high-risk newborns found that daily emollient application from birth did not prevent eczema and was actually associated with more skin infections and a possible increase in food allergy.^[36] So while moisturizing is essential for treating active eczema, it is not a proven strategy for preventing it.

Choosing the Right Moisturizer Vehicle

Not all moisturizers deliver the same level of protection. The vehicle, meaning the base formulation, matters as much as the active ingredients.

• Ointments (e.g., petroleum jelly): Highest occlusive power. White petrolatum reduces transepidermal water loss to roughly 17–31% of baseline, far outperforming hydrogels and most other bases.^[9] Best for very dry, thick plaques and nighttime use.
• Creams: Balance between moisture retention and cosmetic feel. Most patients prefer creams for daytime use. Clinical trials show ceramide-containing and standard creams significantly improve hydration and barrier function over 8 weeks.^[10]
• Lotions: Lightest vehicle with the least occlusive effect. Convenient for large body areas but may not provide enough protection for active eczema.

Fragrance-free formulations are critical. Fragrances are among the most common contact allergens identified in atopic dermatitis patients and can trigger or worsen eczema flares. For a broader look at what sets off flares, see our guide to eczema triggers.^[11] Always check labels for fragrance, dye, and preservative allergens. Our guide to the worst ingredients for eczema helps you decode product labels quickly.

The practical takeaway: Apply your moisturizer at least twice daily, and always within three minutes of bathing to lock in hydration.^[12]

The Soak-and-Seal Method

The soak-and-seal technique amplifies your moisturizer's effect. You soak in lukewarm water for 10 to 15 minutes, gently pat skin until slightly damp, then immediately apply your moisturizer to seal in the water, much like wringing out a sponge and wrapping it in plastic to keep it moist.^[12] Skipping the moisturizer after a bath can actually leave your skin drier than before you started, while following the bath with an emollient boosts hydration well above baseline.^[12]

For severe flares, your doctor may recommend taking this concept further with wet wrap therapy, which adds a layer of damp fabric over the moisturizer to boost absorption. But even the basic soak-and-seal routine can make a noticeable difference in daily comfort.

Topical Prescription Treatments: Steroids and Non-Steroidal Options

When moisturizers alone cannot control your eczema, topical prescription treatments become the next step. These medications target inflammation directly at the skin surface. Several classes are available, each with distinct mechanisms and safety profiles.

Topical Corticosteroids: Potency and Safety

Topical corticosteroids (anti-inflammatory creams and ointments applied directly to the skin) remain the first-line treatment for eczema flares because they suppress the local immune response and reduce redness, swelling, and itch.^[5] The US system classifies their strength into seven categories, ranging from Class 1 (super potent, such as clobetasol propionate) down to Class 7 (least potent, such as 1% hydrocortisone), so think of it like a dimmer switch with seven brightness levels rather than a simple on/off.^[13]

The right potency depends on your flare severity and body location. Thin-skinned areas like the face, eyelids, and groin require low-potency steroids to avoid skin thinning, while thicker skin on palms and soles may need higher potency to penetrate effectively. Real-world data show that long-term steroid use can lead to skin atrophy (a thinning, papery quality to the skin) in up to 77% of users and telangiectasia (small visible blood vessels at the surface) in roughly half.^[14] For guidance on sensitive areas, see our facial eczema treatment guide.

Non-Steroidal Prescription Topicals

Several non-steroidal options now give you and your doctor alternatives, especially for sensitive areas or long-term maintenance.

Tacrolimus 0.03% and pimecrolimus 1% are approved for patients 2 and older, while tacrolimus 0.1% is approved for those 16 and older. Unlike steroids, they do not cause skin atrophy, which makes them valuable for the face and skin folds.^[16] In a Phase IV trial, crisaborole achieved an EASI-75 improvement of −57.5% in infants 3 to under 24 months,^[17] and ruxolitinib cream showed significant itch reduction within 12 hours of the first application, faster than most other topicals.^[18]

For a deeper look at the full range of prescription options, see our guide to atopic dermatitis treatments from topicals to biologics.

Over-the-Counter Treatment Options: The Four Categories

Walk into any pharmacy and you will find dozens of products claiming to help eczema. The problem is that they all look the same on the shelf. In reality, OTC eczema treatments fall into four distinct categories, and each one addresses a different piece of the puzzle.

Understanding these categories helps you stop guessing and start choosing based on what your skin actually needs.

OTC Moisturizers and Prebiotic Moisturizers

Category 1: Plain OTC Moisturizers. These include petroleum jelly, ceramide creams, and basic emollients, all of which address the barrier repair pillar by reducing transepidermal water loss and protecting the skin surface.^[9] What they miss is anti-inflammatory action and active microbiome support, which means that for inflamed eczema, moisturizers alone are not enough.

Category 2: Prebiotic Moisturizers. These newer formulations add ingredients designed to support beneficial skin bacteria while still providing barrier repair. In vitro studies show 1% colloidal oat selectively increases growth of commensal S. epidermidis over pathogenic S. aureus, and clinical use of colloidal oat moisturizers improves microbial diversity in mild-to-moderate atopic dermatitis.^[19] They address two pillars (barrier and microbiome) but still lack direct anti-inflammatory action.

For help choosing between these options, our guide on which cream is good for eczema breaks down the science behind specific ingredients.

OTC Anti-Inflammatories and SmartLotion

Category 3: OTC Anti-Inflammatories. The main option here is 1% hydrocortisone, the only OTC steroid available without a prescription. It provides mild anti-inflammatory relief for minor eczema rashes. However, 1% hydrocortisone is the weakest steroid class and often proves insufficient for anything beyond the mildest flares.^[13] It also does nothing for barrier repair or microbiome balance, and prolonged unsupervised use on the face or skin folds carries risks.

Category 4: All-in-One Prebiotic Anti-Inflammatory Formulations. HarlanMD represents this category with an effective eczema cream that combines low-dose hydrocortisone with prebiotic sulfur designed to support the skin microbiome. By addressing inflammation and microbiome balance in a single OTC formulation, it targets two of the three treatment pillars simultaneously, with the moisturizing base supporting the third. A long-term safety study supports daily use without the side effects typical of stronger steroids.

Some users report a brief stinging sensation during the first few applications, which typically resolves as the barrier begins to heal. Our guide on why eczema cream stings explains the science behind this and how to reduce discomfort. For detailed usage instructions, see the SmartLotion protocol for atopic dermatitis.

Systemic Therapies, Biologics, and Phototherapy for Moderate-to-Severe Eczema

When topical treatments and OTC options cannot control your eczema, the next tier brings in body-wide therapies. These options work from the inside out (biologics, oral JAK inhibitors, traditional immunosuppressants) or apply controlled light energy to calm immune activity in the skin (phototherapy). They represent a major step up in both effectiveness and monitoring requirements.

Biologic Therapies and Oral JAK Inhibitors

Biologics are engineered proteins that target specific immune pathways driving eczema inflammation.

• Dupilumab: Blocks interleukin-4 and interleukin-13. Approved for patients 6 months and older with moderate-to-severe AD. In a pediatric open-label extension, 82% of children achieved EASI-75 and 41% achieved IGA 0/1 at week 52.^[20]
• Tralokinumab: Specifically targets IL-13. In North American Phase 3 trials, EASI-75 was achieved by 40.1% of patients as monotherapy and 58.1% when combined with topical corticosteroids at week 16.^[21]

Oral JAK inhibitors represent the newest class of systemic eczema treatment. They block Janus kinase enzymes inside immune cells, interrupting multiple inflammatory signals at once.

• Upadacitinib: In the head-to-head Heads Up trial, upadacitinib 30 mg achieved EASI-75 in 72.4% of adults versus 62.6% for dupilumab at week 16 (P =.007), with significantly more rapid itch relief.^[23]
• Abrocitinib: A JAK1-selective inhibitor with EASI-75 rates of 40–68% at week 12 depending on dose, and rapid itch improvement as early as week 4.^[24]
• Baricitinib: Approved in Europe for moderate-to-severe AD in adults, with EASI-75 rates of 21–48% across the BREEZE-AD trial program and a favorable safety profile.^[25]

Doctors still use traditional immunosuppressants like cyclosporine, methotrexate, and azathioprine when biologics and JAK inhibitors are unavailable or contraindicated. For a full comparison of systemic options, our guide to atopic dermatitis treatments from topicals to biologics covers each class in depth. These DMARDs require regular laboratory monitoring due to risks including infection, malignancy, bone marrow suppression, hepatotoxicity, and nephrotoxicity.^[26]

Phototherapy and Procedural Options

Phototherapy uses controlled ultraviolet light to calm the immune response in your skin, much like how a few minutes of morning sun can lift your mood, except dosed and targeted by a clinician. Narrowband UVB (NB-UVB) is the preferred and most widely used form because it effectively suppresses Th2, Th22, and Th1 inflammatory pathways while normalizing barrier protein expression.^[27] A typical course involves two to three sessions per week, and the time commitment of traveling to a clinic that often can be a real barrier for many patients.^[27]

PUVA therapy (psoralen plus UVA light) is an older option reserved for cases that do not respond to NB-UVB. A Cochrane review found no clear difference in efficacy compared to NB-UVB, but PUVA carries higher risks including phototoxic reactions, severe irritation, and disease exacerbation.^[28]

For acute severe flares, wet wrap therapy offers a procedural approach that can rapidly reduce inflammation. In a randomized study of children with moderate-to-severe eczema, mean severity scores (SCORAD) improved by 55% with wet wraps over four weeks. For step-by-step instructions, see our complete guide to wet wrap therapy for eczema.^[29]

Natural and Complementary Approaches: What the Evidence Shows

If you have ever scrolled through social media at midnight looking for a "natural" fix after another sleepless, itchy night, you are far from alone. Many people with eczema seek natural treatments, especially after frustration with conventional options. Diet is one area where patients often look for answers, and our guide on diet and eczema reviews the evidence on food triggers and anti-inflammatory eating. Some natural approaches have genuine evidence behind them, while others carry risks that "natural" branding obscures, so the distinction matters. Understanding what causes eczema flare-ups can help you evaluate whether a natural remedy is targeting a real trigger or simply a trend.

What the Evidence Supports

• Colloidal oatmeal: Contains avenanthramides with anti-inflammatory properties. Clinical evidence shows colloidal oat derivatives restore tight junction proteins, reduce TEWL significantly over two weeks, and improve skin sensitivity scores.^[30]
• Coconut oil: Demonstrates antimicrobial activity. Laboratory studies show virgin coconut oil inhibits S. aureus growth and damages bacterial cell walls, with lauric acid driving much of the effect.^[31]
• Vitamin D supplementation: A 2024 meta-analysis of 11 RCTs (686 participants) found vitamin D supplementation modestly reduced eczema severity (SMD −0.41), with stronger effects in mild-to-moderate disease and in patients with low baseline vitamin D.^[32]
• Oral probiotics: Evidence for prevention is strain-specific and mixed. Studies suggest Lactobacillus rhamnosus GG may not significantly reduce eczema risk in high-risk infants regardless of timing.

What to Approach with Caution

• Tea tree oil: Has antimicrobial properties but a 2023 systematic review found side effects reported in 60% of trials, with hypersensitivity contraindications and irritation risk at concentrations ≥25%.^[33]
• Apple cider vinegar: A pilot study of 11 atopic dermatitis subjects found dilute ACV soaks did not significantly alter the skin microbiome or reduce S. aureus, and caused irritation in most participants.^[34]
• Essential oils: Most essential oils are concentrated plant extracts with high allergenic potential and can worsen eczema through contact sensitization.

"Natural" does not mean safe for eczema skin. Always patch-test new products and discuss complementary approaches with your doctor.

For parents exploring gentle options, our guide to the best natural eczema cream for babies evaluates what the evidence actually supports for young children.

Eczema Treatment by Population, Body Location, and Type

Eczema treatment is not one-size-fits-all, and certain populations and body areas need specific considerations. What works for an adult with hand eczema may be inappropriate for a newborn with facial eczema. How dermatitis is treated changes substantially based on age, location, and trigger.

Treating Eczema in Infants and Newborns

Eczema treatment for newborns and infants requires extra caution because their skin is thinner than adult skin, and their smaller bodies have proportionally more surface area, so topical medications absorb more deeply into the bloodstream. Even short-term use of 1% hydrocortisone in children can raise cortisol levels in the blood, a sign the medication is reaching beyond the skin.^[35] Picture water spreading on a paper towel versus a thick cloth, and the difference between infant and adult skin becomes easier to visualize.

• First-line: Frequent emollient application (fragrance-free, dye-free) is the cornerstone of infant eczema management for active disease, though it does not prevent eczema in high-risk infants per the BEEP RCT.^[36]
• Mild flares: Low-potency topical steroids for short, supervised courses.^[35]
• Steroid-sparing options: Crisaborole is approved for infants 3 months and older. Pimecrolimus is approved for children 2 years and older but has evidence supporting safe use in younger infants as well.^[17][16]

For a complete approach to infant eczema, see our evidence-based baby eczema treatment guide.

Contact Dermatitis and Location-Specific Treatment

Contact dermatitis treatment differs from atopic dermatitis management in one critical way: you must identify and remove the trigger. For a full evidence-based protocol, see our contact dermatitis treatment guide. Patch testing using standard allergen series can identify culprits, and copositivity-group analysis helps guide broader avoidance.^[41] Plant dermatitis treatment, for example, requires identifying the offending plant family (urushiol-containing species, compositae) and avoiding cross-reactive exposures. Learn more about irritant contact dermatitis or follow the contact dermatitis treatment protocol.

Scalp eczema treatment requires formulations suited to hair-bearing skin. When seborrheic dermatitis overlaps with atopic eczema on the scalp, ketoconazole 2% shampoo is highly effective: in clinical trials, 89% of patients improved or cleared compared with 44% on placebo.^[37] Our eczema scalp treatment guide covers these options in detail.

Hand eczema is notoriously stubborn because hands face constant exposure to water, soap, and irritants. Treatment often requires potent topical steroids, barrier creams, and strict irritant avoidance. Alitretinoin (9-cis retinoic acid) is the only licensed systemic agent for severe chronic hand eczema unresponsive to potent topical steroids.^[38] Learn more in our guide on why your hand eczema will not heal.

Building Your Eczema Treatment Plan

The most effective eczema treatment plans combine multiple approaches rather than relying on a single product. A randomized trial in children with atopic dermatitis showed combination therapy (emollient + desonide) achieved a 100% effectiveness rate and 52.9% cure rate, versus 60% effectiveness and 0% cure with desonide alone.^[39]

Notice that foundational moisturizing care appears at every severity level, and it never becomes optional. The anti-inflammatory and additional options escalate as severity increases, but the base stays the same.

When to See a Dermatologist

See a dermatologist if your eczema does not improve after two weeks of consistent OTC treatment. Registry data show that antibiotic and oral steroid use spikes dramatically in the months before patients are finally referred to a specialist, which suggests earlier referral could prevent that escalation. If you are managing eczema long-term, our guide on living with eczema covers the daily strategies that reduce reliance on stronger treatments.^[40] You should also seek care if eczema covers large areas, disrupts your sleep, or shows signs of infection such as oozing, crusting, or increased pain. If the 2 a.m. itch is keeping you awake, our guide on sleeping with eczema offers targeted strategies.

Frequently Asked Questions About Eczema Treatment

What Helps Heal Eczema Fast?

The fastest way to calm an eczema flare is to combine a medium-potency topical corticosteroid with intensive moisturizing using the soak-and-seal method. Applying your steroid to damp skin after bathing improves penetration and can produce visible improvement within days.^[12] For severe flares, wet wrap therapy can accelerate results further.^[29] However, "fast" and "lasting" are different goals. Long-term control requires consistent daily care, not just flare treatment.

What Is the 3 Minute Rule for Eczema?

The 3 minute rule means applying your moisturizer within three minutes of bathing, while your skin is still slightly damp. This traps the water your skin absorbed during the bath and seals it in with the emollient layer.^[12] Bathing without follow-up moisturizer can actually decrease hydration below baseline, so consistency with this step matters more than most people realize.

Can Eczema Be Cured Permanently?

There is no permanent cure for eczema, and any claim of "dermatitis how to cure" should be treated with skepticism. Many children with atopic dermatitis do experience significant improvement or remission by adulthood, though remission rates vary by disease severity and study population. For adults, the goal is long-term management that minimizes flares and maintains quality of life. Even severe cases can now reach effectively clear skin with modern biologics and combination therapy.

Which Cream Is Best for Eczema?

The best cream depends on your eczema severity and what your skin needs. For basic maintenance, a fragrance-free ceramide cream repairs the barrier. For active flares, you need an anti-inflammatory component, whether that is a prescription topical steroid, a calcineurin inhibitor, or an OTC option like SmartLotion that combines anti-inflammatory, prebiotic, and moisturizing action in one formulation. Our science-backed cream guide helps you match the right product to your situation.

Is Eczema Treatment Different for Children?

Yes. Children, especially infants, have thinner skin that absorbs topical medications more readily.^[35] This means lower-potency steroids, shorter treatment courses, and closer monitoring are standard. Newer medications like crisaborole are specifically approved for infants 3 months and older.^[17] Emollient therapy is especially important in pediatric eczema, as it supports comfort and reduces reliance on stronger treatments. See our baby eczema treatment guide for age-specific recommendations.

Is There an OTC Eczema Treatment That Addresses All Three Pillars?

Most OTC products target only one or two of the three eczema treatment pillars (barrier repair, inflammation control, microbiome support). Plain moisturizers repair the barrier. Standard 1% hydrocortisone provides mild anti-inflammatory action but no barrier or microbiome benefit. SmartLotion is the only OTC formulation that addresses all three pillars in one product, combining low-dose hydrocortisone with prebiotic sulfur and a built-in moisturizing base. It is safe for all body areas, all ages, and all severity levels, with a long-term safety study supporting daily use.

References

1. Deckers IAG, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. "Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies." PLoS One. 2012. View Study
2. Simpson EL, Guttman-Yassky E, Margolis DJ, et al. "Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis." JAMA Dermatology. 2018. View Study
3. Lugović-Mihić L, Barac E, Tomašević R, Parać E, Zanze L, Ljevar A, Dolački L, Štrajtenberger M. "Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review." Pharmaceuticals (Basel). 2024. View Study
4. Boguniewicz M, Leung DYM. "Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation." Immunological Reviews. 2011. View Study
5. Subramaniam P, Shafiee MN, Md Fadilah NI, Fauzi MB, Maarof M. "Secretome as a novel regenerative strategy for atopic dermatitis: a comprehensive review." Stem Cell Research & Therapy. 2025. View Study
6. Montero-Vilchez T, Segura-Fernández-Nogueras MV, Pérez-Rodríguez I, et al. "Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity." Journal of Clinical Medicine. 2021. View Study
7. Ćorović M, Petrov Ivanković A, Milivojević A, et al. "Investigating the Effect of Enzymatically-Derived Blackcurrant Extract on Skin Staphylococci Using an In Vitro Human Stratum Corneum Model." Pharmaceutics. 2025. View Study
8. Silverberg JI, Lei D, Yousaf M, et al. "Measurement properties of the product of investigator's global assessment and body surface area in children and adults with atopic dermatitis." Journal of the European Academy of Dermatology and Venereology. 2021. View Study
9. Rüther L, Voss W. "Hydrogel or ointment? Comparison of five different galenics regarding tissue breathability and transepidermal water loss." Heliyon. 2021. View Study
10. Wang D-Q, Li X, Zhang R-Y, et al. "Effects of Investigational Moisturizers on the Skin Barrier and Microbiome following Exposure to Environmental Aggressors: A Randomized Clinical Trial and Ex Vivo Analysis." Journal of Clinical Medicine. 2023. View Study
11. Owen JL, Vakharia PP, Silverberg JI. "The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis." American Journal of Clinical Dermatology. 2018. View Study
12. Chiang C, Eichenfield LF. "Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis." Pediatric Dermatology. 2009. View Study
13. Bowie AC, Tadrous M, Egeberg A, et al. "Agreement and Correlation Between Different Topical Corticosteroid Potency Classification Systems." JAMA Dermatology. 2022. View Study
14. Abe M, Igarashi A, Kitajima H, Toyama H, Kabashima K, Saeki H. "Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis." The Journal of Dermatology. 2025. View Study
15. Matsuki F, Suzuki S, Hirose T, et al. "Prescription and application adequacy of topical corticosteroids based on the finger-tip unit method in adult patients with atopic dermatitis: A cross-sectional study." Journal of General and Family Medicine. 2025. View Study
16. Davari DR, Nieman EL, McShane DB, Morrell DS. "Current Perspectives on the Management of Infantile Atopic Dermatitis." Journal of Asthma and Allergy. 2020. View Study
17. Schlessinger J, Shepard JS, Gower R, et al. "Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to <24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)." American Journal of Clinical Dermatology. 2020. View Study
18. Simpson EL, Augustin M, Thaçi D, et al. "Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies." American Journal of Clinical Dermatology. 2025. View Study
19. Liu-Walsh F, Tierney NK, Hauschild J, et al. "Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid." Clinical, Cosmetic and Investigational Dermatology. 2021. View Study
20. Cork MJ, Thaçi D, Eichenfield LF, et al. "Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis." Dermatology and Therapy. 2023. View Study
21. Blauvelt A, Gooderham M, Bhatia N, et al. "Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3." Dermatology and Therapy. 2022. View Study
22. Ferrucci S, Casazza G, Angileri L, et al. "Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience." Journal of Clinical Medicine. 2020. View Study
23. Blauvelt A, Teixeira HD, Simpson EL, et al. "Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial." JAMA Dermatology. 2021. View Study
24. Armstrong AW, Alexis AF, Blauvelt A, et al. "Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis." Dermatology and Therapy. 2024. View Study
25. Radi G, Simonetti O, Rizzetto G, et al. "Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients." Healthcare (Basel). 2021. View Study
26. Yim HJ, Jean T, Ong PY. "Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis." Current Allergy and Asthma Reports. 2024. View Study
27. Molla A. "A Comprehensive Review of Phototherapy in Atopic Dermatitis: Mechanisms, Modalities, and Clinical Efficacy." Cureus. 2024. View Study
28. Musters AH, Mashayekhi S, Harvey J, et al. "Phototherapy for atopic eczema." Cochrane Database of Systematic Reviews. 2021. View Study
29. Hindley D, Galloway G, Murray J, Gardener L. "A randomised study of 'wet wraps' versus conventional treatment for atopic eczema." Archives of Disease in Childhood. 2006. View Study
30. Park J, Shin JY, Kim D, Jun S-H, Jeong ET, Kang N-G. "Dihydroavenanthramide D Enhances Skin Barrier Function through Upregulation of Epidermal Tight Junction Expression." Current Issues in Molecular Biology. 2024. View Study
31. Widianingrum DC, Noviandi CT, Salasia SIO. "Antibacterial and immunomodulator activities of virgin coconut oil (VCO) against Staphylococcus aureus." Heliyon. 2019. View Study
32. Nielsen AY, Høj S, Thomsen SF, Meteran H. "Vitamin D Supplementation for Treating Atopic Dermatitis in Children and Adults: A Systematic Review and Meta-Analysis." Nutrients. 2024. View Study
33. Kairey L, Agnew T, Bowles EJ, Barkla BJ, Wardle J, Lauche R. "Efficacy and safety of Melaleuca alternifolia (tea tree) oil for human health—A systematic review of randomized controlled trials." Frontiers in Pharmacology. 2023. View Study
34. Luu LA, Flowers RH, Gao Y, et al. "Apple cider vinegar soaks do not alter the skin bacterial microbiome in atopic dermatitis." PLoS One. 2021. View Study
35. Luger T, Boguniewicz M, Carr W, et al. "Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants." Pediatric Allergy and Immunology. 2015. View Study
36. Bradshaw LE, Wyatt LA, Brown SJ, et al. "Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT." Health Technology Assessment. 2024. View Study
37. Tynes BE, Johnson CD, Vaish MH, et al. "Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review." Cureus. 2024. View Study
38. Smith IL, Gilberts R, Brown S, et al. "Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial." BMJ Open. 2022. View Study
39. Zhang Y, Chen Y, Li C. "Study on the clinical efficacy of soothing moisturizing repairing cream combined with desonide in the treatment of atopic dermatitis in children." Medicine (Baltimore). 2025. View Study
40. Egeberg A, Thyssen JP, Wu JJ, Pierce E, Ross Terres JA. "Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral." Dermatology and Therapy. 2021. View Study
41. Warshaw EM, Maibach HI, Taylor JS, et al. "North American Contact Dermatitis Group Patch Test Results: 2011-2012." Dermatitis. 2015. View Study